TDX Ethosuximide
FDA 510(k) K850174 · Abbott Laboratories
510(k) numberK850174
Submission
- Device name
- TDX Ethosuximide
- Applicant
- Abbott Laboratories
Abbott Park, IL, US - Received
- January 17, 1985
- Decision date
- February 6, 1985
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
Device classification
- Product code
- DLF – Enzyme Immunoassay, Ethosuximide
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.3380
- Specialty
- Clinical Toxicology
Other 510(k)s with product code DLF
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K881607 | Easy-Test Emit(R) Ethosuximide (Eths) Item 16647DLF · Traditional | Em Diagnostic Systems, Inc. | 06/01/1988SE |
| K844204 | Emit QST Ethosuximide AssayDLF · Traditional | Syva Co. | 12/11/1984SE |
| K832797 | Modifica- of Emit AED Ethosuximide AssayDLF · Traditional | Syva Co. | 09/29/1983SE |
| K823801 | Ames Tda Ethosuximide TestDLF · Traditional | Miles Laboratories, Inc. | 01/14/1983SE |
| K823745 | Advance Emit-Aed EthosuximideDLF · Traditional | Syva Co. | 01/07/1983SE |
| K792584 | Aca Ethosurimide Test PackDLF · Traditional | E.I. Dupont DE Nemours & Co., Inc. | 12/31/1979SE |
| K780461 | Analyzer-Supplement, Kinetic, LKB 2086DLF · Traditional | Syva Co. | 04/12/1978SE |
| K780380 | Analyzer, Fast, Centrifugal, GemsaecDLF · Traditional | Syva Co. | 04/12/1978SE |
More from Syva Co.
| 510(k) | Device | Decision |
|---|---|---|
| K252424 | Anti-HCV NextMZO · Traditional | 04/28/2026SE |
| K243500 | ARCHITECT iGentamicinLCD · Special | 07/09/2025SE |
| K243168 | Alinity i Rubella IgGLFX · Traditional | 06/20/2025SE |
| K243283 | Alinity h-series SystemGKZ · Traditional | 02/20/2025SE |
| K233932 | Alinity i Toxo IgMLGD · Traditional | 08/30/2024SE |
| K232669 | TbiQAT · Special | 09/29/2023SE |
| K222850 | HAVAb IgG IILOL · Traditional | 08/10/2023SE |
| K220031 | Alinity h-series SystemGKZ · Traditional | 08/04/2023SE |
| K220282 | i-STAT PTplus Cartridge with the i-STAT 1 SystemGJS · Traditional | 07/14/2023SE |
| K230937 | Alinity i Total ß-hCG Reagent Kit, GLP systems TrackDHA · Traditional | 06/05/2023SE |
Questions and answers
When was TDX Ethosuximide cleared by the FDA?
TDX Ethosuximide (K850174) received a 510(k) decision of Substantially Equivalent on February 6, 1985, 20 days after the submission was received.
What is the product code of K850174?
The FDA product code is DLF – Enzyme Immunoassay, Ethosuximide, a Class II (moderate risk) device regulated under 21 CFR 862.3380.